Mara Leyzin, MD | |
8025 Castor Ave, Philadelphia, PA 19152-2733 | |
(215) 745-9900 | |
(215) 745-9902 |
Full Name | Mara Leyzin |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 8025 Castor Ave, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003992579 | NPI | - | NPPES |
001153363 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QA0000X | Family Medicine - Adolescent Medicine | MD032043E (Pennsylvania) | Secondary |
207Q00000X | Family Medicine | MD032043E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mara Leyzin, MD 8025 Castor Ave, Philadelphia, PA 19152-2733 Ph: (215) 745-9900 | Mara Leyzin, MD 8025 Castor Ave, Philadelphia, PA 19152-2733 Ph: (215) 745-9900 |
News Archive
The Rare Disease Cures Accelerator-Data and Analytics Platform initiative officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation.
UC biologists have turned to amphibian sources - specifically frogs and tadpoles - to help shed light on how early stressors in the womb and shortly after birth may play a part in the onset of adult diseases such as diabetes and cardiovascular disease.
A recent Special Issue of Business Horizons (www.elsevier.com/locate/bushor), the journal of the Kelley School of Business, Indiana University, and published by Elsevier, addresses issues central to healthcare and life sciences. Healthcare reform, for example, has been at the center of U.S. political debate in recent years with renewed attempts to gain bipartisan support from Congress for passage of a national system of health insurance coverage.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
A review of more than 80 studies reveals that changes in the immune cells of people with human immunodeficiency virus (HIV) infection may increase their risk of cardiovascular disease (CVD). The review is published in the journal Physiology.
› Verified 6 days ago
Srikar Vegesna, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2118 Cottman Ave, Philadelphia, PA 19149 Phone: 215-342-3020 Fax: 215-342-3653 | |
Chelsea Tiffany Salas-tam, Family Medicine Medicare: Medicare Enrolled Practice Location: 833 Chestnut St Ste 301, Philadelphia, PA 19107 Phone: 215-955-7190 | |
Meng-chao Lee, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Central Ave Ste 104, Philadelphia, PA 19111 Phone: 215-742-0712 Fax: 215-742-5218 | |
Carol Bowes-lawlor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 E Chestnut Hill Ave, Philadelphia, PA 19118 Phone: 215-753-9080 Fax: 215-753-8830 | |
Dr. Seung Hee Hong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 150, Philadelphia, PA 19134 Phone: 215-926-3535 Fax: 215-926-3536 | |
Dr. Denise Hamilton Christian, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 251 E Bringhurst St, Philadelphia, PA 19144 Phone: 215-844-1020 Fax: 215-844-8147 |